Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Anas Younes, MD from the Memorial Sloan Kettering Cancer Center, New York, NY discusses the cost of new drugs in lymphoma. Prof Younes argues that the impact of these drugs on the lives of young patients outweighs concerns around their cost.
Recorded at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting, in Chicago, IL.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.